Johns Hopkins Medicine Office of Continuing Medical Education
Skip Navigation.
How ToAbout CMECME CalendarOnline/EnduringProgramsResources & DownloadsContact & Travel InformationBlog
CME Online
Forgot your password?

Not Registered yet?

Create a new account.

80022096: Buprenorphine Certification Training

November 13, 2009
  • Send to Colleague
  • Back to List
Buprenorphine Certification Training Image


Description:
Opioid use is very prevalent in the US:
-2.5 million people have used heroin at least once in their lifetime (NHSDA, 2001)
-There are about 900,000 heroin users in the US (ONDCP, 2002)
-Lifetime use of a pain reliever for other than medical purposes: 22 million people (NHSDA, 2001)
-Use of a pain reliever for other than medical purposes in the last month: 3.5 million people (NHSDA, 2001)

The 2000 Drug Abuse Treatment Act allowed physicians in office-based settings to prescribe (and pharmacists to dispense) schedule III, IV, and V “narcotics” to treat opioid addiction. Federal legislation requires physicians to do 8 hours of buprenorphine training to be certified to provide office-based opioid treatment. After this certification training, physicians can obtain a special DEA number necessary for treatment. The activity will provide 8hours of training as required, and have forms available on the day of training for participants to request their number from the DEA. Additionally the course will focus on other professional topics such as treatment guidelines, limitations, counseling and other pharmacological and non-pharmacological services.

Who Should Attend:
This activity is intended for Medical Students, Residents, Fellows, Attendings, and Physicians in Private Practice in the following specialties:
- Psychiatry
- Internal Medicine
- Family / Primary Care Medicine

Other Professionals (and students):
- Physician Assistants and Nurse Practitioners
- Registered Nurses
- Social Workers
- Counselors / Therapists
- Psychologists

Objectives:
After attending this activity, the participant will demonstrate the ability to:
-Recognize legislative changes that have led to the availability of office-based treatment of opioid dependence in the United States
-Describe general opioid pharmacology and the pharmacology of buprenorphine and buprenorphine/naloxone
-Discuss the efficacy and safety of buprenorphine and how it compares to other pharmacologic treatments for opioid dependence
-Identify appropriate candidates and practice clinical management skills for office-based treatment of opioid dependence

Program Schedule:
7:OO A.M. - 5:15 P.M.
[CLICK BELOW FOR A COMPLETE SCHEDULE LISTING]
Program Schedule

Johns Hopkins Speakers:
Eric Strain, MD - Activity Director
Professor of Psychiatry and Behavioral Sciences

Amina Chaudhry, MD, MPH
Assistant Professor of Medicine

Kenneth Stoller, MD
Assistant Professor of Psychiatry and Behavioral Sciences
Johns Hopkins Bayview Medical Center

Michael Fingerhood, MD
Associate Professor of Medicine

Location:
The Johns Hopkins Preclinical Teaching Building
725 North Wolfe Street
Baltimore, Maryland 21205

The Preclinical Teaching Building is located on East Baltimore Campus of The Johns Hopkins Medical Institutions. Directions and campus parking information are available on our website under the contact and travel section at www.HopkinsCME.edu. Handicapped parking is available in the nearby Rutland Garage. Johns Hopkins is smoke-free.

Fees:
REGISTRATION CUT-OFF DATE: November 9, 2009

Methods of Payment: Payment by check or credit card must accompany the registration form prior to the activity. On-site payments by credit card only. Foreign payments must be by credit card or with a U.S. Dollar World Money Order. The registration fee includes instructional materials, continental breakfast, refreshment breaks and lunch.

Non-Baltimore City Practicing Physicians, Attendings, Fellows, Residents, private or public practice ……..$150

Baltimore City Practicing Physicians, Attendings, Fellows, Residents, private or public practice ……..$No Charge*

Allied Health Professionals (RNs, NPs, Pas, Psychologists, Counselors, Therapists and Social Workers)….. $125

*If you are a physician in practice within Baltimore City, your registration fee is complimentary. Please provide your work address and contact information so that we may verify your practice location.

You will receive a confirmation by e-mail if you have provided your e-mail address. Otherwise confirmation will be sent by mail. If you have not received it by November 9, 2009, call (410) 502-9634 to confirm that you are registered. Certificates of attendance will be mailed by December 28, 2009.

The Johns Hopkins University reserves the right to cancel or postpone any activity due to unforeseen circumstances. In this event, the University will refund the registration fee but is not responsible for travel expenses.

Late Fee and Refund Policy:
A $50 late fee applies to all registrations received after 5:00 p.m. EST on November 9, 2009. A handling fee of $50 will be deducted for cancellation. Refund requests must be received by fax or mail by November 9, 2009. No refunds will be made thereafter. Transfer of registration to another Johns Hopkins conference in lieu of cancellation is not possible.

Prerequisites:
Physician registrants will need to bring with them:
- DEA Number (if applicable)
- State Medical License Number (if applicable)
- Photo ID

Hotel and Travel Information:
A listing of local hotel suggestions is available from the main page on this webiste (www.HopkinsCME.edu) or by calling the Office of Continuing Medical Education.

For airline accommodations, please call United Airlines at (800) 521-4041 for discounted rates and refer to Meeting ID Number 549TJ.

Americans with Disabilities Act:
The Johns Hopkins University School of Medicine fully comply with the legal requirements of the ADA and the rules and regulations thereof. Please notify us if you have any special needs.


Talks

November 13, 2009  8:00 AM to 8:15 AM

Welcome and Introduction

Strain, Eric
November 13, 2009  8:15 AM to 8:45 AM

Course Introduction, Overview of Opioid Abuse, Legislative Changes Allowing Office-Based Opioid Dependence Treatment

Strain, Eric
To describe the legislative changes which allow office-based opioid treatment.
November 13, 2009  8:45 AM to 9:15 AM

General Opioid Pharmacology, Pharmacology of Buprenorphine and Buprenorphine/Naloxone

Strain, Eric
To explain and characterize the pharmacological profile of naloxone, buprenorphine and buprenorphine/naloxone.
November 13, 2009  9:15 AM to 10:00 AM

Efficacy and Safety of Buprenorphine

Chaudhry, Amina
To be familiar with efficacy data for buprenorphine. To understand safety issues with buprenorphine.
November 13, 2009  10:15 AM to 11:00 AM

Clinical Use of Buprenorphine

Fingerhood, Michael
To use buprenorphine in outpatient setting.
November 13, 2009  11:00 AM to 11:30 AM

Overview of Methadone, Naltrexone and Clonidine

Stoller, Kenneth
To describe the characteristics and clinical use of methodone, naltrexone and uonidine in the treatment of opioid dependence.
November 13, 2009  11:30 AM to 12:00 PM

Patient Assessment/Selection

Stoller, Kenneth
To list the elements of patient assessment for buprenorphine maintenance including those which may predict potential success.
November 13, 2009  12:00 PM to 12:45 PM

LUNCH with Waiver form

Chaudhry, Amina
November 13, 2009  12:45 PM to 1:15 PM

Clinical Management

Fingerhood, Michael
To use buprenorphine in clincal setting.
November 13, 2009  1:15 PM to 1:45 PM

Small Group/Case # 1

Strain, Eric
To describe the clinical features of opioid dependence, evaluation for the disorder and its treatment.
November 13, 2009  1:15 PM to 1:45 PM

Small Group/Case # 1

Stoller, Kenneth
To describe the clinical features of opioid dependence, evaluation for the disorder, and its treatment.
November 13, 2009  1:15 PM to 1:45 PM

Small Group/Case # 1

Fingerhood, Michael
To describe the clinical features of opioid dependence, evaluation for the disorder and its treatment.
November 13, 2009  1:15 PM to 1:45 PM

Small Group/Case # 1

Chaudhry, Amina
To describe the clinical features of opioid dependence, evaluation for the disorder and its treatment.
November 13, 2009  1:45 PM to 2:30 PM

Medical Comorbidity

Chaudhry, Amina
To describe common medical comorbidities in persons with history of opioid dependence.
November 13, 2009  1:45 PM to 2:30 PM

Psychiatric Comorbidity

Stoller, Kenneth
To discuss the core features of psychiatric conditions that commonly occur in patients with opioid dependence.
November 13, 2009  2:45 PM to 3:15 PM

Confidentiality, Record Keeping, and Office Policies and Procedures

Fingerhood, Michael
To know the rules for safely using buprenorphine.
November 13, 2009  3:15 PM to 3:45 PM

Special Treatment Populations, Pain

Chaudhry, Amina
To manage pain in buprenorphine maintained patients. To understand the treatment of opioid dependence in certain special populations.
November 13, 2009  3:45 PM to 4:15 PM

Small Group / Case # 2

Strain, Eric
To discuss the optimal diagnosis of opioid dependence.
November 13, 2009  3:45 PM to 4:15 PM

Small Group / Case # 2

Stoller, Kenneth
To discuss the optimal diagnosis of opioid dependence.
November 13, 2009  3:45 PM to 4:15 PM

Small Group / Case # 2

Fingerhood, Michael
To discuss the optimal diagnosis of opioid dependence.
November 13, 2009  3:45 PM to 4:15 PM

Small Group / Case # 2

Chaudhry, Amina
To discuss the optimal diagnosis of opioid dependence.
November 13, 2009  4:15 PM to 4:45 PM

Small Group / Case # 3

Strain, Eric
To explain dose induction and risks associated with buprenorphine treatment for opioid dependence.
November 13, 2009  4:15 PM to 4:45 PM

Small Group / Case # 3

Stoller, Kenneth
To explain dose induction and risks associated with buprenorphine treatment for opioid dependence.
November 13, 2009  4:15 PM to 4:45 PM

Small Group / Case # 3

Fingerhood, Michael
To explain dose induction and risks associated with buprenorphine treatment for opioid dependence.
November 13, 2009  4:15 PM to 4:45 PM

Small Group / Case # 3

Chaudhry, Amina
To explain dose induction and risks associated with buprenorphine treatment for opioid dependence.
November 13, 2009  4:45 PM to 5:15 PM

Questions and Answers, Program Evaluation

Strain, Eric
November 13, 2009  4:45 PM to 5:15 PM

Questions and Answers, Program Evaluation

Stoller, Kenneth
November 13, 2009  4:45 PM to 5:15 PM

Questions and Answers, Program Evaluation

Fingerhood, Michael
November 13, 2009  4:45 PM to 5:15 PM

Questions and Answers, Program Evaluation

Chaudhry, Amina

Policy On Speaker And Provider Disclosure

It is the policy of the Johns Hopkins University School of Medicine that the speaker and provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosure will be made in the activity handout materials.

Event Information
Johns Hopkins Preclinical Teaching Bldg.
,
Directions

Target Audience(s)

Addiction medicine, substance abuse specialists, family practice, general practice, internal medicine, preventive medicine, social work and psychiatry

Contact Info

410.502.9634 or cmenet@jhmi.edu

Contact Info

General Info: 410.502.9634

Mailing Address:
Johns Hopkins University School
of Medicine
Thomas B. Turner Building
720 Rutland Avenue, Room 20
Baltimore, Maryland 21205-2195

Email Us

© 2010 Johns Hopkins University
School of Medicine | Office of Continuing Medical Education
Home | Privacy Policy | Sitemap
Managed Hosting by PEER 1
HTML to PDF conversion by ABCpdf.NET